Cai Wenjun/Shanghai Daily news

Greater emphasis on diagnostics will give patients better individualized health care and help control medical costs, especially in expensive cancer therapy, industry insiders told a briefing in the city yesterday.

Cancer therapy has undergone a major revolution in recent years, characterized by the introduction of targeted drugs that inhibit specific molecules. But these medications are very expensive and not useful to all patients with the same cancer.